SEC Form 4 · accession 0001179110-16-031999
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James M. Roach
Officer — Senior VP, Development and Chi
Period of report
Nov 21, 2016
Accepted (ET)
Nov 23, 2016 · 10:41 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 21, 2016 | S | 416 | $13.45 | D | 156,056 | D | |
| Common Stock | Nov 21, 2016 | S | 425 | $13.45 | D | 155,631 | D | |
| Common Stock | Nov 22, 2016 | S | 250 | $14.40 | D | 155,381 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 19, 2009.